Pluspharma
NDC Package 51645-860-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Pluspharma is a . Marketed by Gemini Pharmaceuticals, Inc. Dba Plus Pharma, this product is identified by NDC 51645-860 and is authorized under FDA application part332.

Identification & Billing

NDC Package Code
51645-860-01
Package Description
100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
Product Code
51645-860
11-Digit Billing Format
51645086001

Clinical Specifications

Proprietary Name
Pluspharma
Dosage Form
-

Regulatory & Marketing

Labeler Name
Gemini Pharmaceuticals, Inc. Dba Plus Pharma
FDA Application #
part332
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-27-2006
End Marketing Date
05-31-2021
Listing Expiration
05-31-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51645-860-01 identifies a specific commercial package of 100 tablet, chewable in 1 bottle, plastic of Pluspharma, labeled by Gemini Pharmaceuticals, Inc. Dba Plus Pharma. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Gemini Pharmaceuticals, Inc. Dba Plus Pharma on March 27, 2006. The current certification is valid through May 31, 2021.

How is this Gemini Pharmaceuticals, Inc. Dba Plus Pharma product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51645086001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51645-860-01
11-Digit CMS (5-4-2)
51645-0860-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.